| Abstrakt: |
A recent study conducted by Norton Healthcare in Louisville, Kentucky, aimed to define the epidemiology and outcomes of community-acquired pneumonia (CAP) in immunocompromised hosts (ICHs) compared to non-ICHs. The study found that approximately 10% of hospitalized patients with CAP were immunocompromised, with advanced-stage cancer being the most common immunocompromising condition. The research also revealed that ICHs had a higher mortality rate compared to non-ICHs, with a 2-fold increase in mortality. Geospatial analysis showed that clusters of ICHs hospitalized with CAP were found in areas associated with low-income and Black or African American populations. [Extracted from the article] |
